sivopixant   Click here for help

GtoPdb Ligand ID: 11756

Synonyms: compound 28 [PMID: 34587541] | S-600918
Compound class: Synthetic organic
Comment: Sivopixant (S-600918) is a clinical stage, oral P2X3 ion channel antagonist [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 9
Topological polar surface area 128.34
Molecular weight 507.13
XLogP 5.7
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Clc1ccc(cc1)Cn1c(Nc2ccc(cc2)Oc2ccccn2)nc(=O)n(c1=O)C[C@@H](C(=O)O)C
Isomeric SMILES C[C@@H](Cn1c(=O)nc(n(c1=O)Cc1ccc(cc1)Cl)Nc1ccc(cc1)Oc1ccccn1)C(=O)O
InChI InChI=1S/C25H22ClN5O5/c1-16(22(32)33)14-31-24(34)29-23(30(25(31)35)15-17-5-7-18(26)8-6-17)28-19-9-11-20(12-10-19)36-21-4-2-3-13-27-21/h2-13,16H,14-15H2,1H3,(H,32,33)(H,28,29,34)/t16-/m0/s1
InChI Key SKZQFKBIJUXXCG-INIZCTEOSA-N
No information available.
Summary of Clinical Use Click here for help
Sivopixant (S-600918) has been advanced to clinical evaluation, as a potential an antitussive agent to treat refractory chronic cough.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT04110054 Evaluation of S-600918 in Adults With Refractory Chronic Cough Phase 2 Interventional Shionogi Inc.